Being able to personalize a patient's treatment is one of the cornerstones of nuclear medicine, but how are we able to do that? PET-Guided radiotherapy is one answer. In addition to staging and defining a disease, PET imaging can also give providers important information about what's going on in the body while a patient is undergoing their treatment regimen. PET can be used to adjust radiotherapy based on changes in the body and disease progression — whether higher doses are needed in areas with more aggressive cancer, or lower, but still effective, doses can be administered to ensure the minimal amount of toxicity to a patient. Join us for this episode of the JNM Podcast as host Ken Herrmann talks with radiotherapy experts Wolfgang Fendler and Nancy Lee. Listen on YouTube or wherever you stream podcasts.

This episode is sponsored by GE Healthcare: https://www.gehealthcare.com/products/molecular-imaging